A

ACELYRIN Inc
NASDAQ:SLRN

Watchlist Manager
ACELYRIN Inc
NASDAQ:SLRN
Watchlist
Price: 5.16 USD -13.71% Market Closed
Market Cap: 515m USD
Have any thoughts about
ACELYRIN Inc?
Write Note

ACELYRIN Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ACELYRIN Inc
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
ACELYRIN Inc
NASDAQ:SLRN
Total Current Liabilities
$85.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$43.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$11.7B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$20.3B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$4B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.7B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
24%

See Also

What is ACELYRIN Inc's Total Current Liabilities?
Total Current Liabilities
85.2m USD

Based on the financial report for Dec 31, 2023, ACELYRIN Inc's Total Current Liabilities amounts to 85.2m USD.

What is ACELYRIN Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 1Y
436%

Over the last year, the Total Current Liabilities growth was 436%.

Back to Top